Search research articles
Contact Us
Filters
Showing results (61-70 of 101) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1988
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation
X Calvet, F Pons, J Bruix, et al.
Gut
|
January 5, 2002
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
J M Llovet, X Mas, J J Aponte, et al.
Hepatology (Baltimore, Md.)
|
June 10, 1998
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution
J Bruix, J M Llovet, A Castells, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1986
Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension
R Mastai, L Grande, J Bosch, et al.
Gastroenterology
|
August 1, 1994
nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma
L Boix, J Bruix, E Campo, et al.
Journal of Hepatology
|
May 1, 1990
Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases
X Calvet, J Bruix, C Brú, et al.
Gastroenterology
|
March 1, 1989
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage
J Rigau, J Bosch, J M Bordas, et al.
Acta Cytologica
|
May 1, 1993
Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy
M Solé, X Calvet, T Cuberes, et al.
International Journal of Cancer
|
September 15, 1990
Risk factors for hepatocellular carcinoma in Catalonia, Spain
M V Mayans, X Calvet, J Bruix, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1994
Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials
J Bruix, A Castells, X Montanyà, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 101) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1988
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation
X Calvet, F Pons, J Bruix, et al.
Gut
|
January 5, 2002
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
J M Llovet, X Mas, J J Aponte, et al.
Hepatology (Baltimore, Md.)
|
June 10, 1998
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution
J Bruix, J M Llovet, A Castells, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1986
Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension
R Mastai, L Grande, J Bosch, et al.
Gastroenterology
|
August 1, 1994
nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma
L Boix, J Bruix, E Campo, et al.
Journal of Hepatology
|
May 1, 1990
Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases
X Calvet, J Bruix, C Brú, et al.
Gastroenterology
|
March 1, 1989
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage
J Rigau, J Bosch, J M Bordas, et al.
Acta Cytologica
|
May 1, 1993
Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy
M Solé, X Calvet, T Cuberes, et al.
International Journal of Cancer
|
September 15, 1990
Risk factors for hepatocellular carcinoma in Catalonia, Spain
M V Mayans, X Calvet, J Bruix, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1994
Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials
J Bruix, A Castells, X Montanyà, et al.
Page
of 11